Cargando…

HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia

Detalles Bibliográficos
Autores principales:	Liu, Z, Patel, CA, Campbell, A, Fu, A, Benson, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232765/ http://dx.doi.org/10.1016/j.jval.2022.04.1028

Ejemplares similares

PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia
por: Pesa, J., et al.
Publicado: (2021)

Real‐world effectiveness of antipsychotics
por: Tiihonen, J.
Publicado: (2016)

Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States
por: Martin, Amber, et al.
Publicado: (2022)

Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey
por: Keenan, Alexander, et al.
Publicado: (2022)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China
por: Zhang, Lei, et al.
Publicado: (2019)

A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia
por: Chen, Yifan, et al.
Publicado: (2022)

Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
por: Barlati, Stefano, et al.
Publicado: (2022)

Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
por: Dickson, Matthew C., et al.
Publicado: (2022)

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
por: Lin, Dee, et al.
Publicado: (2021)

T223. REAL WORLD EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS IN PATIENTS WITH SCHIZOPHRENIA: A 10-YEARS RETROSPECTIVE STUDY
por: Lee, Tae Young, et al.
Publicado: (2018)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders
por: Fabrazzo, Michele, et al.
Publicado: (2022)

Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy
por: Yazici, Esra, et al.
Publicado: (2017)

Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
por: Gamón, Verónica, et al.
Publicado: (2021)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia
por: Basu, Anirban, et al.
Publicado: (2023)

HSD103 Impact of COVID-19 on Delivery of Cancer Care: Real-World Insights from Community Oncology Research Evaluations (CORE)
por: Manimaran, R., et al.
Publicado: (2023)

HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England
por: King, R, et al.
Publicado: (2022)

A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
por: Katona, Lajos, et al.
Publicado: (2021)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
por: Apiquian, Rogelio, et al.
Publicado: (2004)

Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
por: Fisher, Maxine D, et al.
Publicado: (2014)

Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
por: Vadiei, Nina, et al.
Publicado: (2022)

RWD26 Real World Evidence for the Impact of COVID-19 Pandemic on the Incidence of Multiple Myeloma in Germany
por: Schilling, S, et al.
Publicado: (2022)

Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries With Schizophrenia
por: Li, Pengxiang, et al.
Publicado: (2023)

A Study of an Antipsychotic Prescription Pattern of Patients with Schizophrenia in a Developing Country
por: Ramadas, Smitha, et al.
Publicado: (2010)

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy
por: Kim, Hee-Yun, et al.
Publicado: (2014)

Antipsychotic patterns in outpatients with schizophrenia in China: A cross sectional study
por: Guo, Xiaobing, et al.
Publicado: (2021)

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
por: MacEwan, Joanna P., et al.
Publicado: (2016)

Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
por: Correll, Christoph U., et al.
Publicado: (2022)

Real-world treatment patterns and outcomes in patients initiating lurasidone for the treatment of schizophrenia in Europe
por: Jones, A., et al.
Publicado: (2022)

HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020
por: Tisza, B, et al.
Publicado: (2022)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia
por: Joshi, Kruti, et al.
Publicado: (2018)

Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
por: Doane, Michael J., et al.
Publicado: (2022)

Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum: Real-world evidence from a Spanish hospital setting
por: Galmes, Lluis Niell, et al.
Publicado: (2023)

Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia
por: Lu, Chenyue, et al.
Publicado: (2022)

HSD93 Investigating the Impact of COVID-19 on Haemodialysis
por: Rice, CT, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ucppbcpo783iql69i4bq07hbr